{"author": "Jian, LY ", "adress": "China Med Univ, Shengjing Hosp, Dept Pharm, Shenyang 110004, Peoples R China", "emails": ["wangshu521@163.com", "liumingyue18@163.com", "lsiheng@163.com", "liunaimingcoco@163.com", "zhangguibin9@sina.com", "zhaoqingchun1967@163.com", "zhangyingshi526@163.com", "jianly@sj-hospital.org"], "title": "Which Is the Most Appropriate PI3K Inhibitor for Breast Cancer Patients with or without PIK3CA Status Mutant? A Systematic Review and Network Meta-Analysis"}